Biosimilar Bevacizumab Enables Medicare Cost Savings, Expands Cancer Treatment Access
Study shows biosimilar bevacizumab reduces Medicare costs for metastatic colorectal and lung cancer treatments, expanding patient access without raising spending.
U.S. Health Insurance Premiums Outpace Worker Earnings Due to Hospital Cost Increases
U.S. health insurance premiums have surged due to rising hospital costs driven by consolidation and executive incentives. Regulatory price controls and employer plan designs aim to manage escalating premiums.
U.S. Prescription Drug Denials by Private Insurers Increase 25% from 2016 to 2023
Analysis shows a 25% increase in U.S. private insurer prescription drug denials from 2016-2023, driven by rising drug costs and claim automation. Insights into industry impact and reform efforts.
$1 Trillion Medicaid and ACA Cuts Threaten New York Health Coverage
Explore how $1 trillion in federal Medicaid and ACA funding cuts will impact New York's health coverage, rural hospitals, and SNAP nutrition support, with significant economic repercussions.
Hospitals Face Financial Challenges Serving Medicare Inpatient Fee-for-Service Cases
Analysis reveals most hospitals lose money on Medicare inpatient fee-for-service cases, with stronger financial performance in for-profit versus not-for-profit and teaching hospitals due to cost and payment structures.
Medicare Expansion for GLP-1 Agonists Balances Clinical Gains and Cost Risks
New analysis projects increased Medicare spending with expanded GLP-1 receptor agonist coverage for obesity, highlighting clinical benefits and financial challenges.